drugset / Trial / NCT03830489

Impact of a Predictive Score of Bowel Preparation Quality in Clinical Practice

NCT03830489

Phase 4 Completed 260 enrolled Hospital Universitario de Canarias
RandomizedParallel-groupSingle-blindOther

Summary

This is a single center randomized controlled trial to compare the colon cleansing quality determined by the Boston Bowel Preparation Scale achieved by two strategies in patients with high risk of poor colon cleansing defined as those patients with a score\> 1.225 following a predictive score previously published: one group will receive an intensified split-dose 4 L polyethylene glycol solution (PEG) plus bisacodyl and 3 days of fiber-free diet and the other group a split-dose 2 L PEG solution with ascorbic plus bisacodyl and 1 day of fiber-free diet. Patients with a score ≤ 1.225 will receive a split-dose 2 L PEG solution with ascorbic plus bisacodyl and 1 day of fiber-free diet.

Timeline

Start
2019-02-04
Primary completion
2019-10-21
Completion
2019-10-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin C Other / unclassified
Subject polyethylene glycol Other / unclassified 2 ml
Subject polyethylene glycol Other / unclassified 4 ml
Background Bisacodyl Small molecule 10 mg Oral

Indications

No indication recorded.